Calidi Biotherapeutics Inc
CLDI0.601USD
+0.011+1.86%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
19.12MMarket Cap
LossP/E TTM
Calidi Biotherapeutics Inc
0.601
+0.011+1.86%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-86.14%-7.13M
-4.57%-5.42M
63.41%-4.95M
-6.21%-5.49M
-23.30%-3.83M
-33.80%-5.19M
-216.19%-13.52M
-74.94%-5.17M
-47.53%-3.11M
-41.20%-3.88M
---4.28M
---2.96M
---2.11M
---2.75M
Net income from continuing operations
29.94%-5.06M
49.59%-4.15M
-150.44%-5.07M
53.87%-5.77M
-11.81%-7.22M
-6.10%-8.23M
62.20%-2.02M
-173.19%-12.50M
16.51%-6.46M
-122.30%-7.76M
---5.36M
---4.58M
---7.74M
---3.49M
Operating gains losses
-10.78%91.00K
-1.01%98.00K
17.24%102.00K
-11.50%100.00K
9.68%102.00K
1.02%99.00K
40.32%87.00K
135.42%113.00K
78.85%93.00K
104.17%98.00K
--62.00K
--48.00K
--52.00K
--48.00K
Other non-cash items
-44.97%268.00K
120.32%251.00K
98.11%-83.00K
-97.19%199.00K
-73.21%487.00K
-140.72%-1.23M
-169.31%-4.39M
291.21%7.07M
179.69%1.82M
1653.18%3.03M
---1.63M
--1.81M
--650.00K
--173.00K
Change in working capital
-258.32%-3.04M
-175.30%-2.25M
92.92%-588.00K
17.16%-777.00K
19070.00%1.92M
1066.99%2.99M
-623.79%-8.30M
20.03%-938.00K
-99.71%10.00K
-378.38%-309.00K
--1.58M
---1.17M
--3.47M
--111.00K
-Change in prepaid expenses
-120.13%-317.00K
29.26%-249.00K
135.94%468.00K
102.48%7.00K
656.54%1.57M
-137.84%-352.00K
-4440.00%-1.30M
-386.21%-282.00K
-181.79%-283.00K
49.83%-148.00K
--30.00K
---58.00K
--346.00K
---295.00K
-Change in other current liabilities
----
----
----
----
----
--1.50M
----
----
----
----
----
----
----
--510.00K
Cash from non-recurring investing activities
Cash from operating activities
-86.14%-7.13M
-4.57%-5.42M
63.41%-4.95M
-6.21%-5.49M
-23.30%-3.83M
-33.80%-5.19M
-216.19%-13.52M
-74.94%-5.17M
-47.53%-3.11M
-41.20%-3.88M
---4.28M
---2.96M
---2.11M
---2.75M
Investing cash flow
Net cash from continuing investing activities
40.00%7.00K
-92.86%5.00K
-91.67%6.00K
-100.00%0.00
-96.35%5.00K
-56.52%70.00K
7.46%72.00K
202.97%306.00K
38.38%137.00K
519.23%161.00K
--67.00K
--101.00K
--99.00K
--26.00K
Capital expenditures
40.00%7.00K
-92.86%5.00K
-91.67%6.00K
-100.00%0.00
-96.35%5.00K
-56.52%70.00K
7.46%72.00K
202.97%306.00K
38.38%137.00K
519.23%161.00K
--67.00K
--101.00K
--99.00K
--26.00K
Net cash flow from disposal of fixed assets
40.00%7.00K
-92.86%5.00K
-91.67%6.00K
-100.00%0.00
-96.35%5.00K
-56.52%70.00K
7.46%72.00K
202.97%306.00K
38.38%137.00K
519.23%161.00K
--67.00K
--101.00K
--99.00K
--26.00K
Net cash flow from investment products
----
----
----
----
----
--35.00K
100.00%0.00
--63.00K
----
100.00%0.00
---66.00K
----
----
---1.00K
Net cash flow from other investing activities
----
--0.00
----
----
----
--0.00
--9.00K
----
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
-40.00%-7.00K
85.71%-5.00K
90.48%-6.00K
100.00%0.00
96.35%-5.00K
78.26%-35.00K
52.63%-63.00K
-140.59%-243.00K
-38.38%-137.00K
-496.30%-161.00K
---133.00K
---101.00K
---99.00K
---27.00K
Financing cash flow
Cash flow from continuous financing activities
169.10%8.11M
543.07%13.11M
-72.06%6.05M
-20.91%5.20M
-20.52%3.01M
-168.49%-2.96M
408.36%21.64M
136.51%6.58M
417.90%3.79M
189.48%4.32M
--4.26M
--2.78M
--732.00K
--1.49M
Net cash flow from debt Issuance/repayment
-152.47%-1.67M
99.17%-19.00K
3523.53%582.00K
-306.34%-1.82M
36.29%3.18M
-241.24%-2.30M
-100.90%-17.00K
97.54%883.00K
6760.00%2.33M
2328.36%1.63M
--1.89M
--447.00K
---35.00K
--67.00K
Net cash flow from common stock issuance/repurchase
--3.50M
--0.00
--1.00M
----
----
----
----
----
----
--0.00
----
----
----
--0.00
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
--0.00
--19.35M
--5.15M
----
----
----
----
----
----
Proceeds from stock option exercised by employees
----
----
----
----
-100.00%0.00
--0.00
--50.00K
--50.00K
58.77%181.00K
--0.00
--0.00
--0.00
--114.00K
--0.00
Proceeds from issuance of warrants
----
--1.97M
--2.73M
--2.24M
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
-83.54%-301.00K
23.94%-502.00K
-112.01%-271.00K
-227.24%-626.00K
-112.82%-164.00K
-124.52%-660.00K
-4.57%2.26M
-78.91%492.00K
95.87%1.28M
88.91%2.69M
--2.36M
--2.33M
--653.00K
--1.43M
Net cash from non-recurrent financing activities
Net cash from financing activities
169.10%8.11M
543.07%13.11M
-72.06%6.05M
-20.91%5.20M
-20.52%3.01M
-168.49%-2.96M
408.36%21.64M
136.51%6.58M
417.90%3.79M
189.48%4.32M
--4.26M
--2.78M
--732.00K
--1.49M
Net cash flow
Beginning cash balance
352.65%9.81M
-79.59%2.12M
-53.89%1.05M
19.70%1.36M
267.29%2.17M
3355.00%10.37M
386.38%2.29M
50.00%1.14M
-73.63%590.00K
-91.47%300.00K
--470.00K
--758.00K
--2.24M
--3.52M
Current period cash flow changes
220.35%970.00K
193.85%7.69M
-86.87%1.06M
-126.72%-307.00K
-247.35%-806.00K
-2926.90%-8.20M
4852.35%8.08M
498.96%1.15M
136.98%547.00K
122.67%290.00K
---170.00K
---288.00K
---1.48M
---1.28M
Effect of exchange rate changes
----
184.21%16.00K
-243.48%-33.00K
-30.00%-13.00K
--17.00K
-337.50%-19.00K
227.78%23.00K
0.00%-10.00K
100.00%0.00
700.00%8.00K
---18.00K
---10.00K
---6.00K
--1.00K
Ending cash balance
691.99%10.78M
352.65%9.81M
-79.59%2.12M
-53.89%1.05M
19.70%1.36M
267.29%2.17M
3355.00%10.37M
386.38%2.29M
50.00%1.14M
-73.63%590.00K
--300.00K
--470.00K
--758.00K
--2.24M
Free cash flow
-86.08%-7.14M
-3.27%-5.43M
63.56%-4.95M
-0.27%-5.49M
-18.25%-3.84M
-30.20%-5.26M
-212.97%-13.59M
-79.17%-5.48M
-47.12%-3.24M
-45.69%-4.04M
---4.34M
---3.06M
---2.21M
---2.77M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
